scholarly journals Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer

BMC Cancer ◽  
2015 ◽  
Vol 15 (1) ◽  
Author(s):  
Masaru Matsumoto ◽  
Masahiro Seike ◽  
Rintaro Noro ◽  
Chie Soeno ◽  
Teppei Sugano ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Mtor Inhibitor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Inhibitor Treatment

scholarly journals Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment

2018 ◽  
Vol Volume 10 ◽  
pp. 5537-5544 ◽  
Author(s):  
Stefan Diem ◽  
Mirjam Fässler ◽  
Omar Hasan Ali ◽  
Marco Siano ◽  
Rebekka Niederer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Risk Score ◽  
Cell Lung Cancer ◽  
Checkpoint Inhibitor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Inhibitor Treatment

scholarly journals Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases

Lung Cancer ◽  
2015 ◽  
Vol 89 (1) ◽  
pp. 76-79 ◽  
Author(s):  
Vivek Subbiah ◽  
Jenny Berry ◽  
Michael Roxas ◽  
Nandita Guha-Thakurta ◽  
Ishwaria Mohan Subbiah ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Brain Metastases ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Mtor Inhibitor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Cns Activity

Multi-kinase RET inhibitor vandetanib combined with mTOR inhibitor everolimus in patients with RET rearranged non-small cell lung cancer.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 9035-9035 ◽  
Author(s):  
Vivek Subbiah ◽  
Tina Cascone ◽  
Kenneth R. Hess ◽  
Ishwaria Mohan Subbiah ◽  
Sarah Nelson ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Mtor Inhibitor ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document